Skip to main content

Table 5 Comparison of planar-based whole-body (T1/2, WB) and SPECT-based abdominal effective half-lives (T1/2, SPECT) for Lu-177-PSMA-617 and Lu-177-Octreotate therapy

From: Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach

Patient T1/2, WB [h] T1/2, SPECT [h]
Octreotate
 P1 40 53
 P2 43 61
 P3 43 56
 P4 52 73
 P5 62 87
 Median 43 61
PSMA-617
 P6 22 33
 P7 31 50
 P8 65 67
 P9 39 31
 P10 29 42
 Median 31 42